Journal Article Summary
The article investigates the occurrence of oral-buccal-lingual dyskinesia (AID) in patients with Parkinson's disease (PD) who are treated with anticholinergic medications. This topic is significant because while anticholinergics are commonly prescribed to manage tremors in PD, they can lead to involuntary movements in the mouth and face, which can severely impact a patient's quality of life. Understanding the factors that contribute to AID can help healthcare providers make better treatment decisions and improve patient outcomes.
The study analyzed medical records from three university hospitals, focusing on 1,429 PD patients, of whom 247 received anticholinergic therapy. Out of these, 13 patients developed AID, while 164 did not. Key findings revealed that patients with AID were generally older at the onset of PD and exhibited milder motor symptoms compared to those without AID. The research also indicated that the initiation of anticholinergic therapy occurred later in life for those who developed AID, suggesting a potential link between age and the risk of developing this condition.
However, the study has several limitations. The sample size for patients with AID was relatively small, which may affect the reliability of the findings. Additionally, distinguishing AID from other movement disorders can be challenging, as symptoms may overlap with those of tardive dyskinesia or other drug-induced dyskinesias. Patients experiencing involuntary movements should discuss their symptoms and treatment options with a healthcare professional to ensure appropriate management and to consider the risks associated with anticholinergic medications.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Ha Joonyoung, Kang Suk Yun, Baik Kyoungwon, Sohn Young H., Lee Phil Hyu, Baek Min Seok, Hong Jin Yong. Factors associated with anticholinergic-induced oral-buccal-lingual dyskinesia in Parkinson’s disease. Journal of Movement Disorders 2024. DOI: 10.14802/jmd.23069. PMID: 37736680. PMCID: PMC10846963.
Featured Pill Pals Product
Benztropine 0.5 mg Tablets --- Generic For Cogentin --- Leading Pharma
Benztropine 0.5 mg Tablets — Generic For Cogentin — Leading Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
